Skip to main content
. 2023 May 26;14:1146517. doi: 10.3389/fendo.2023.1146517

Table 4.

Risk of hospitalization, ICU admission, IMV and mortality based on the presence of comorbidities in the overall population.

Overall population
(N=3,402)
Non-obesity with obesity-related comorbidity Obesity without obesity-related comorbidity Obesity with obesity-related comorbidity
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Hospitalization 1.85 (1.49-2.28) <0.001 1.67 (1.30-2.14) <0.001 2.29 (1.84-2.87) <0.001
ICU admission 1.31 (0.78-2.21) 0.314 1.15 (0.64-2.05) 0.638 1.34 (0.80-2.25) 0.265
IMV 1.19 (0.69-2.08) 0.532 1.25 (0.69-2.28) 0.459 1.49 (0.87-2.54) 0.146
Mortality (30-day) 1.12 (0.74-1.69) 0.592 0.76 (0.37-1.58) 0.468 1.22 (0.79-1.87) 0.353
Mortality (in-hospital) 0.99 (0.68-1.47) 0.985 0.83 (0.44-1.58) 0.573 1.03 (0.69-1.54) 0.873

CI, confidence Interval; ICU, intensive care unit; IMV, invasive medical ventilation; OR, Odds ratio.

Reference categories: non-obesity without any obesity-related comorbidity. Results adjusted for age and sex Obesity-related comorbidities have been previously defined in this text as diabetes mellitus, arterial hypertension, and cardiovascular disease. The logistic regression analysis for the variables “ICU admission”, “IMV” and “mortality” were calculated in the total number of patients requiring hospital admission (N=2,040).